Christina A. Waters
No más puestos en curso
Perfil
Christina A.
Waters held several positions in the biopharmaceutical industry, including Director of Scientific Development at Novartis Institute for Functional Genomics, Manager of Preclinical Studies Program at Miravant Medical Technologies, President of CTI Sede Secondaria at CTI BioPharma Corp., President and COO at aTyr Pharma, Associate at Howard Hughes Medical Institute, and President at Systems Medicine, Inc. She also served as Chief Development and Marketing Officer at The Multiple Myeloma Research Foundation.
Waters earned an undergraduate degree from San Diego State University, a doctorate from the University of California, Davis, and an MBA from the University of California, Los Angeles.
Antiguos cargos conocidos de Christina A. Waters.
| Empresas | Cargo | Fin |
|---|---|---|
Howard Hughes Medical Institute, Inc.
 Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Howard Hughes Medical Institute, Inc. engages in the provision of biomedical research services and science education programs. It funds grants to both institutions and individuals in support of a wide range of science and research-related initiatives, including precollege and undergraduate science education, pre- and post-doctoral research fellowships, and international research activities. The company was founded by Howard R. Hughes in 1953 and is headquartered in Chevy Chase, MD. | Corporate Officer/Principal | - |
The Multiple Myeloma Research Foundation, Inc.
 The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Multiple Myeloma Research Foundation, Inc. provides funding for research on myeloma treatment. It provides funding to laboratories worldwide, including compounds and approaches in clinical trials and pre-clinical studies. The firm also facilitates clinical trials through their affiliate organization, the Multiple Myeloma Research Consortium. The company was founded by Karen E. Andrews and Kathryn E. Giusti in 1998 and is headquartered in Norwalk, CT. | Ventas & Marketing | - |
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Director Técnico/Científico/I+D | - |
Systems Medicine, Inc.
 Systems Medicine, Inc. Pharmaceuticals: OtherHealth Technology Systems Medicine, Inc. develops oncology products by integrating predictive cellular pharmacogenomics. The company is based in Tucson, AZ. The company was founded by Jeffrey E. Jacob. Systems Medicine was acquired by CTI BioPharma Corp. on July 31, 2007 for $35 million. | Presidente | - |
| MIRAVANT MEDICAL TECHNOLOGIES INC. | Corporate Officer/Principal | - |
Formación de Christina A. Waters.
| University of California, Davis | Doctorate Degree |
| San Diego State University | Undergraduate Degree |
| University of California, Los Angeles | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| MIRAVANT MEDICAL TECHNOLOGIES INC. | Health Technology |
| Empresas privadas | 5 |
|---|---|
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
Systems Medicine, Inc.
Systems Medicine, Inc. Pharmaceuticals: OtherHealth Technology Systems Medicine, Inc. develops oncology products by integrating predictive cellular pharmacogenomics. The company is based in Tucson, AZ. The company was founded by Jeffrey E. Jacob. Systems Medicine was acquired by CTI BioPharma Corp. on July 31, 2007 for $35 million. | Health Technology |
Novartis Institute for Functional Genomics, Inc.
Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Commercial Services |
Howard Hughes Medical Institute, Inc.
Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Howard Hughes Medical Institute, Inc. engages in the provision of biomedical research services and science education programs. It funds grants to both institutions and individuals in support of a wide range of science and research-related initiatives, including precollege and undergraduate science education, pre- and post-doctoral research fellowships, and international research activities. The company was founded by Howard R. Hughes in 1953 and is headquartered in Chevy Chase, MD. | Miscellaneous |
The Multiple Myeloma Research Foundation, Inc.
The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Multiple Myeloma Research Foundation, Inc. provides funding for research on myeloma treatment. It provides funding to laboratories worldwide, including compounds and approaches in clinical trials and pre-clinical studies. The firm also facilitates clinical trials through their affiliate organization, the Multiple Myeloma Research Consortium. The company was founded by Karen E. Andrews and Kathryn E. Giusti in 1998 and is headquartered in Norwalk, CT. | Commercial Services |
- Bolsa de valores
- Insiders
- Christina A. Waters
